Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial.

Bruna R, Benedetti F, Boccomini C, Patti C, Barbui AM, Pulsoni A, Musso M, Liberati AM, Gini G, Castellino C, Rossini F, Ciceri F, Rota-Scalabrini D, Stelitano C, Di Raimondo F, Tucci A, Devizzi L, Zoli V, Zallio F, Narni F, Dondi A, Parvis G, Semenzato G, Lanza F, Perrone T, Angrilli F, Billio A, Gueli A, Mantoan B, Rambaldi A, Gianni AM, Corradini P, Passera R, Ladetto M, Tarella C.

Haematologica. 2019 Nov;104(11):2241-2248. doi: 10.3324/haematol.2018.209932. Epub 2019 Apr 11.

2.

Lenalidomide-based induction and maintenance in elderly newly diagnosed multiple myeloma patients: updated results of the EMN01 randomized trial.

Bringhen S, D'Agostino M, Paris L, Ballanti S, Pescosta N, Spada S, Pezzatti S, Grasso M, Rota-Scalabrini D, De Rosa L, Pavone V, Gazzera G, Aquino S, Poggiu M, Santoro A, Gentile M, Baldini L, Petrucci MT, Tosi P, Marasca R, Cellini C, Palumbo A, Falco P, Hájek R, Boccadoro M, Larocca A.

Haematologica. 2019 Oct 3. pii: haematol.2019.226407. doi: 10.3324/haematol.2019.226407. [Epub ahead of print]

3.

Safe Use of Carfilzomib in a Patient with Multiple Myeloma and Intermittent Type 1 Brugada ECG Pattern: A Case Report.

Ghisoni E, Marandino L, Lombardi P, Bonzano A, Becco P, Aglietta M, Fizzotti M, Gay F, Rota Scalabrini D.

Acta Haematol. 2019 Sep 25:1-5. doi: 10.1159/000502538. [Epub ahead of print]

PMID:
31553985
4.

Post-Transplant Cyclophosphamide and Tacrolimus-Mycophenolate Mofetil Combination Prevents Graft-versus-Host Disease in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors.

Carnevale-Schianca F, Caravelli D, Gallo S, Coha V, D'Ambrosio L, Vassallo E, Fizzotti M, Nesi F, Gioeni L, Berger M, Polo A, Gammaitoni L, Becco P, Giraudo L, Mangioni M, Sangiolo D, Grignani G, Rota-Scalabrini D, Sottile A, Fagioli F, Aglietta M.

Biol Blood Marrow Transplant. 2017 Mar;23(3):459-466. doi: 10.1016/j.bbmt.2016.12.636. Epub 2016 Dec 27.

5.

Reduced intensity VEPEMB regimen compared with standard ABVD in elderly Hodgkin lymphoma patients: results from a randomized trial on behalf of the Fondazione Italiana Linfomi (FIL).

Zallio F, Tamiazzo S, Monagheddu C, Merli F, Ilariucci F, Stelitano C, Liberati AM, Mannina D, Vitolo U, Angelucci E, Rota Scalabrini D, Vallisa D, Bellei M, Bari A, Ciccone G, Salvi F, Levis A.

Br J Haematol. 2016 Mar;172(6):879-88. doi: 10.1111/bjh.13904. Epub 2016 Jan 13.

PMID:
26763986
6.

Complete remission of paraneoplastic vanishing bile duct syndrome after the successful treatment of Hodgkin's lymphoma: a case report and review of the literature.

Rota Scalabrini D, Caravelli D, Carnevale Schianca F, D'Ambrosio L, Tolomeo F, Boccone P, Manca A, De Rosa G, Nuzzo A, Aglietta M, Grignani G.

BMC Res Notes. 2014 Aug 14;7:529. doi: 10.1186/1756-0500-7-529. Review.

7.

Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive program.

Ladetto M, Lobetti-Bodoni C, Mantoan B, Ceccarelli M, Boccomini C, Genuardi E, Chiappella A, Baldini L, Rossi G, Pulsoni A, Di Raimondo F, Rigacci L, Pinto A, Galimberti S, Bari A, Rota-Scalabrini D, Ferrari A, Zaja F, Gallamini A, Specchia G, Musto P, Rossi FG, Gamba E, Evangelista A, Vitolo U; Fondazione Italiana Linfomi.

Blood. 2013 Nov 28;122(23):3759-66. doi: 10.1182/blood-2013-06-507319. Epub 2013 Oct 1.

8.

Pomalidomide, cyclophosphamide, and prednisone for relapsed/refractory multiple myeloma: a multicenter phase 1/2 open-label study.

Larocca A, Montefusco V, Bringhen S, Rossi D, Crippa C, Mina R, Galli M, Marcatti M, La Verde G, Giuliani N, Magarotto V, Guglielmelli T, Rota-Scalabrini D, Omedé P, Santagostino A, Baldi I, Carella AM, Boccadoro M, Corradini P, Palumbo A.

Blood. 2013 Oct 17;122(16):2799-806. doi: 10.1182/blood-2013-03-488676. Epub 2013 Aug 16.

9.

Bendamustine with or without rituximab for the treatment of heavily pretreated non-Hodgkin's lymphoma patients : A multicenter retrospective study on behalf of the Italian Lymphoma Foundation (FIL).

Rigacci L, Puccini B, Cortelazzo S, Gaidano G, Piccin A, D'Arco A, Freilone R, Storti S, Orciuolo E, Zinzani PL, Zaja F, Bongarzoni V, Balzarotti M, Rota-Scalabrini D, Patti C, Gobbi M, Carpaneto A, Liberati AM, Bosi A, Iannitto E.

Ann Hematol. 2012 Jul;91(7):1013-22. doi: 10.1007/s00277-012-1422-5. Epub 2012 Feb 15.

PMID:
22349722
10.

ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned.

Viviani S, Zinzani PL, Rambaldi A, Brusamolino E, Levis A, Bonfante V, Vitolo U, Pulsoni A, Liberati AM, Specchia G, Valagussa P, Rossi A, Zaja F, Pogliani EM, Pregno P, Gotti M, Gallamini A, Rota Scalabrini D, Bonadonna G, Gianni AM; Michelangelo Foundation; Gruppo Italiano di Terapie Innovative nei Linfomi; Intergruppo Italiano Linfomi.

N Engl J Med. 2011 Jul 21;365(3):203-12. doi: 10.1056/NEJMoa1100340.

11.

Complete resolution of life-threatening bleomycin-induced pneumonitis after treatment with imatinib mesylate in a patient with Hodgkin's lymphoma: hope for severe chemotherapy-induced toxicity?

Carnevale-Schianca F, Gallo S, Rota-Scalabrini D, Sangiolo D, Fizzotti M, Caravelli D, Capaldi A, Anselmetti G, Palesandro E, D'Ambrosio L, Coha V, Obert R, Aglietta M, Grignani G.

J Clin Oncol. 2011 Aug 20;29(24):e691-3. doi: 10.1200/JCO.2011.35.6733. Epub 2011 Jun 27. No abstract available.

12.

Bendamustine with or without rituximab in the treatment of relapsed chronic lymphocytic leukaemia: an Italian retrospective study.

Iannitto E, Morabito F, Mancuso S, Gentile M, Montanini A, Augello A, Bongarzoni V, D'Arco A, Di Renzo N, Fazzi R, Franco G, Marasca R, Mulè A, Musso M, Musto P, Pennese E, Piccin A, Rota-Scalabrini D, Visani G, Rigacci L.

Br J Haematol. 2011 May;153(3):351-7. doi: 10.1111/j.1365-2141.2011.08597.x. Epub 2011 Mar 4.

PMID:
21371003
13.

Percutaneous vertebroplasty in multiple myeloma: prospective long-term follow-up in 106 consecutive patients.

Anselmetti GC, Manca A, Montemurro F, Hirsch J, Chiara G, Grignani G, Carnevale Schianca F, Capaldi A, Rota Scalabrini D, Sardo E, Debernardi F, Iussich G, Regge D.

Cardiovasc Intervent Radiol. 2012 Feb;35(1):139-45. doi: 10.1007/s00270-011-0111-4. Epub 2011 Feb 9.

14.

Dose-dense and high-dose chemotherapy plus rituximab with autologous stem cell transplantation for primary treatment of diffuse large B-cell lymphoma with a poor prognosis: a phase II multicenter study.

Vitolo U, Chiappella A, Angelucci E, Rossi G, Liberati AM, Cabras MG, Botto B, Ciccone G, Gaidano G, Falchi L, Freilone R, Novero D, Orsucci L, Pavone V, Pogliani E, Rota-Scalabrini D, Salvi F, Tonso A, Tucci A, Levis A; Gruppo Italiano Multiregionale Linfomi e Leucemie (GIMURELL).

Haematologica. 2009 Sep;94(9):1250-8. doi: 10.3324/haematol.2009.007005. Epub 2009 Jul 7.

15.

Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage.

Ladetto M, De Marco F, Benedetti F, Vitolo U, Patti C, Rambaldi A, Pulsoni A, Musso M, Liberati AM, Olivieri A, Gallamini A, Pogliani E, Rota Scalabrini D, Callea V, Di Raimondo F, Pavone V, Tucci A, Cortelazzo S, Levis A, Boccadoro M, Majolino I, Pileri A, Gianni AM, Passera R, Corradini P, Tarella C; Gruppo Italiano Trapianto di Midollo Osseo (GITMO); Intergruppo Italiano Linfomi (IIL).

Blood. 2008 Apr 15;111(8):4004-13. doi: 10.1182/blood-2007-10-116749. Epub 2008 Jan 31.

PMID:
18239086
16.

Allogeneic nonmyeloablative hematopoietic cell transplantation in metastatic colon cancer: tumor-specific T cells directed to a tumor-associated antigen are generated in vivo during GVHD.

Carnevale-Schianca F, Cignetti A, Capaldi A, Vitaggio K, Vallario A, Ricchiardi A, Sperti E, Ferraris R, Gatti M, Grignani G, Rota-Scalabrini D, Geuna M, Fizzotti M, Sangiolo D, Sottile A, De Rosa G, Bucci AR, Lambertenghi-Deliliers G, Benedetti E, Nash R, Aglietta M.

Blood. 2006 May 1;107(9):3795-803. Epub 2006 Jan 10.

PMID:
16403911
17.

Allogeneic hemopoietic stem cell transplantation in solid tumors.

Carnevale-Schianca F, Ricchiardi A, Capaldi A, Bucci AR, Grignani G, Rota-Scalabrini D, Fizzotti M, Aliberti S, Aglietta M.

Transplant Proc. 2005 Jul-Aug;37(6):2664-6. Review.

PMID:
16182778
18.

A large-scale study of bone marrow involvement in patients with Hodgkin's lymphoma.

Levis A, Pietrasanta D, Godio L, Vitolo U, Ciravegna G, Di Vito F, Gavarotti P, Guglielmelli T, Orsucci L, Raviolo E, Rota Scalabrini D, Salvi F, Tonso A, Aglietta M, Boccadoro M, Gallamini A, Saglio G, Scassa E, Gallo E.

Clin Lymphoma. 2004 Jun;5(1):50-5.

PMID:
15245608
19.

Idarubicin in patients with diffuse large cell lymphomas: a randomized trial comparing VACOP-B (A = doxorubicin) vs VICOP-B (I = idarubicin).

Bertini M, Freilone R, Botto B, Calvi R, Gallamini A, Gatti AM, Liberati AM, Meneghini V, Orlandi E, Orsucci L, Pizzuti M, Rota Scalabrini D, Salvi F, Todeschini G, Vitolo U, Resegotti L.

Haematologica. 1997 May-Jun;82(3):309-13.

20.

Combined modality treatment with a weekly brief chemotherapy (ACOP-B) followed by locoregional radiotherapy in localized-stage intermediate- to high-grade non-Hodgkin's lymphoma.

Freilone R, Botto B, Vitolo U, Bertini M, Audisio E, Calvi R, Cucchi M, De Crescenzo A, Gallamini A, Ghio R, Griso L, Levis A, Massara G, Orsucci L, Ricardi U, Rota Scalabrini D, Salvi F, Secondo V, Resegotti L.

Ann Oncol. 1996 Nov;7(9):919-24.

PMID:
9006742
21.

Results of a low aggressivity chemotherapy regimen (CVP/CEB) in elderly Hodgkin's disease patients.

Levis A, Depaoli L, Bertini M, Botto B, Ciravegna G, Freilone R, Gallamini A, Gavarotti P, Ricardi U, Rota Scalabrini D, Salomone A, Salvi F, Vitolo U, Pileri A, Sannazzari GL, Resegotti L.

Haematologica. 1996 Sep-Oct;81(5):450-6.

22.

The treatment of elderly patients with aggressive non-Hodgkin's lymphomas: feasibility and efficacy of an intensive multidrug regimen.

Bertini M, Freilone R, Vitolo U, Botto B, Ciotti R, Cinieri S, Di Nota A, Di Vito F, Levis A, Orsucci L, Pini M, Rota-Scalabrini D, Todeschini G, Resegotti L.

Leuk Lymphoma. 1996 Aug;22(5-6):483-93.

PMID:
8882962
23.

Probability of cure in elderly Hodgkin's disease patients.

Levis A, Depaoli L, Urgesi A, Bertini M, Orsucci L, Vitolo U, Buchi G, Gallamini A, Gavarotti P, Novarino A, Rota Scalabrini D, Mazza U, Pileri A, Sannazzari GL, Resegotti L.

Haematologica. 1994 Jan-Feb;79(1):46-54.

24.

Malignant lymphoproliferative disorders in liver cirrhosis.

Lombardo L, Rota Scalabrini D, Vineis P, De La Pierre M.

Ann Oncol. 1993 Mar;4(3):245-50. Review.

PMID:
8471557
25.

[Liver cirrhosis and lymphoproliferative diseases: coincidence or association?].

Lombardo L, Rota Scalabrini D, Fracchia M, Torchio B, De La Pierre M.

Recenti Prog Med. 1991 Jul-Aug;82(7-8):372-7. Italian.

PMID:
1947400
26.

Mitoxantrone, etoposide, cisplatin and dexamethasone (MEPD) as salvage chemotherapy in resistant non-Hodgkin's lymphoma.

Vitolo U, Orsucci L, Bertini M, Cavallero G, Gallamini A, Ghio R, Levis A, Rota-Scalabrini D, Resegotti L.

Haematologica. 1991 Jan-Feb;76(1):43-6.

PMID:
2055560
27.

[The lymphocytogram in recurrent aphthous stomatitis. The etiopathogenic aspects].

Ratis G, Poccardi G, Rota Scalabrini D, Pomatto E, Vercellino V.

Minerva Stomatol. 1991 Jan-Feb;40(1-2):45-9. Italian.

PMID:
2041531
28.

Phenotypical characterization of lymphocyte recirculating subsets in patients undergoing splenectomy for trauma.

Massaioli N, Mainardi SM, Paron L, Redivo L, Rota Scalabrini D, Poccardi G.

Ann Ital Chir. 1990 May-Jun;61(3):273-5; discussion 275-6.

PMID:
2291507
29.

Severe platelet dysfunction in a patient with autoantibodies against membrane glycoproteins IIb-IIIa.

Balduini CL, Grignani G, Sinigaglia F, Bisio A, Pacchiarini L, Rota Scalabrini D, Balduini C, Mauri C, Ascari E.

Haemostasis. 1987;17(1-2):98-104.

PMID:
3596362
30.

Role of arachidonate metabolites in the genesis of cerebral vasospasm.

Rodriguez y Baena R, Gaetani P, Grignani G, Pacchiarini L, Vigano' T, Rota Scalabrini D, Silvani V, Folco G, Paoletti P.

Adv Prostaglandin Thromboxane Leukot Res. 1987;17B:938-42. No abstract available.

PMID:
2960206
31.

Effect of plasma protease inhibitors on tumor cell-induced platelet aggregation.

Pacchiarini L, Pagliarino M, Rota Scalabrini D, Grignani G, Rizzo SC.

Haematologica. 1986 May-Jun;71(3):269. No abstract available.

PMID:
3093335
32.

Structure and "in vitro" functions of platelets stored as platelet concentrates at room temperature.

Balduini CL, Sinigaglia F, Grignani G, Bisio A, Rota Scalabrini D, Mazzucco M, Pacchiarini L, Balduini C.

Haematologica. 1986 May-Jun;71(3):177-82. No abstract available.

PMID:
3093319
33.

[Platelet aggregation and resistance to osmotic shock of platelet concentrates obtained by discontinuous-flow cell separation with the surge pump technic].

Longoni P, Rota Scalabrini D, Cascone G, Veroni C, Lo Faro A.

Boll Soc Ital Biol Sper. 1984 Mar 30;60(3):649-55. Italian.

PMID:
6712834

Supplemental Content

Loading ...
Support Center